MAF Antibody - N-terminal region

Artikelnummer: ASB-ARP38607_P050
Artikelname: MAF Antibody - N-terminal region
Artikelnummer: ASB-ARP38607_P050
Hersteller Artikelnummer: ARP38607_P050
Alternativnummer: ASB-ARP38607_P050-25UL,ASB-ARP38607_P050-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: IHC, WB
Spezies Reaktivität: Bovine, Canine, Equine, Guinea pig, Human, Mouse, Porcine, Rabbit, Rat, Zebrafish
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human MAF
Alternative Synonym: CCA4, AYGRP, c-MAF, CTRCT21
MAF acts as a transcriptional activator or repressor. It is involved in embryonic lens fiber cell development. It recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. MAF is also involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. When overexpressed, MAF represses anti-oxidant reponse element (ARE)-mediated transcription. It may be involved either as an oncogene or as a tumor suppressor, depending on the cell context.
Klonalität: Polyclonal
Konzentration: 0.5 mg/ml
Molekulargewicht: 38kDa
NCBI: 4094
UniProt: O75444
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
ARP38607_P050
25 ug of the indicated Human whole cell extracts was loaded onto a 12% SDS-PAGE gel. 0.3 ug/mL of the antibody was used in this experiment. The protein may be modified by glycosylation.
WB Suggested Anti-MAF Antibody Titration: 0.2-1 ug/ml
ELISA Titer: 1:1562500
Positive Control: Hela cell lysate
MAF antibody - N-terminal region (ARP38607_P050) in Human HeLa using Western Blot